In this podcast, Dr. Danish Bhatti is explaining Vascular movement disorders. …
Blog Posts
In this podcast, Dr. Danish Bhatti is explaining the difference between start hesitation and gait freezing. …
In this podcast, Dr. Danish Bhatti is talking about Cerebral Palsy, a question asked by his student in Mini-fellowship in MD course. …
Welcome, everyone, to our new podcast on movement disorders. These podcast will be a series of mini lectures, which are 3-7 minute long audio clips discussing a very particular topic or a very particular question with a practical, useful, relevant detail or information. So it could be a discussion on something like how do you examine a patient’s gait? How do you diagnose someone with cerebral palsy? or what is the difference between spasticity and rigidity? What is the difference …
Managing a Brain Herniation from a Spinal Tap with Dr. Bertoni …
Dr. Bertoni and a neurological examination with a young patient. …
Dr. Bertoni meets a CPR instructor who is short of breath after little walking. …
Dr. Bertoni discusses neurological disorders for suicide victim. …
Covid-19 pandemic challenge provided us with impetus to innovate and provide rapid solutions. We have successfully launched multiple tele-education online learning programs through a Pakistani diaspora and local physician collaborative that have been extremely effective. The programs were launched form the platform of Association of Physicians of Pakistani Descent of North America (APPNA) and include Daily Covid-19 Webinars, Weekly Case Discussions, online discussion groups, themed webinars on psychosocial health of physicians, ventilator management, critical care nursing and primary care. So …
gLIDe Study: A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease (ClinicalTrials.gov Identifier: NCT03922711) The University of Nebraska Medical Center (UNMC) Department of Neurological Sciences is always looking to bring clinical trials with new drug development to our patients with Parkinson’s disease. We feel this is important because it not only provides much needed help in development of new drugs for patients with this disabling …
